Biopsy Devices Market

  • ID: 4332780
  • Report
  • Region: Global
  • 132 pages
  • MedDeviceTracker
1 of 3
The Market for Biopsy Devices is Anticipated to Increase to an Estimated $2.3Bn by 2021

This analysis includes a discussion of products, competitors, market forecasts, and opportunities in the global market for biopsy devices.

Topics Covered Include:

  • An overview of biopsy devices, including biopsy guidance systems, needle-based biopsy products, and other biopsy devices (biopsy forceps, curettes, and shave/punch biopsy products).
  • Global and country/region-specific market forecasts, including forecasts by product segment.
  • Competitive analyses by product segment.
  • Discussion of key drivers and limiters to the biopsy devices market.
  • Country and region-specific insights that are shaping the biopsy devices market.

Report Highlights:

  • Biopsy devices are most commonly utilized in the diagnosis of cancer. The global incidence of cancer continues to increase, driving sales of biopsy devices.
  • Biopsy guidance system sales are expected to account for the largest share of total market sales, while the needle-based biopsy devices segment will register the largest growth.
  • The market for biopsy devices is anticipated to experience healthy growth during the forecast period (2016-21), increasing to an estimated $2.3bn by 2021.
  • Sophisticated biopsy devices are driving market growth. Biopsy guidance systems and vacuum-assisted biopsy devices are anticipated to remain major contributors to total market growth due to these devices improving the quality of tissue samples acquired and reducing procedure times and patient complications.
  • The US market for biopsy devices accounted for approximately 48% of all sales, followed by the five major European markets (France, Germany, Italy, Spain, and the UK).
  • The strongest growth in biopsy product sales is expected to occur in the Rest of the World market segment, which is being driven by demand for more sophisticated healthcare services in emerging markets.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
Executive Summary
i. Methodology

1. Cancer Statistics Update
1.1 Cancer prevalence and mortality
1.2 Bibliography

2. Biopsy Devices and Biopsy Guidance System
2.1 Core needle biopsy
2.1.1 Products
2.2 Fine needle aspiration biopsy
2.2.1 Products
2.3 Vacuum-assisted biopsy
2.3.1 Products
2.4 Endoscopic biops
2.5 Open/surgical biopsy
2.6 Bone and bone marrow biopsy
2.6.1 Products
2.7 Other types of biopsy products
2.8 Biopsy guidance systems
2.8.1 Products
2.9 Emerging products/technologies
2.10 Bibliography

3. Biopsy Products Market
3.1 Global competitors
3.1.1 Biopsy guidance systems competitive analysis
3.1.2 Needle-based biopsy products competitive analysis
3.2 Market forecast: US
3.2.1 Biopsy guidance systems market: US
3.2.2 Needle-based biopsy products market: US
3.2.2.1 Competitors
3.2.3 Other biopsy products market: US
3.3 Market forecast: five major EU markets
3.3.1 Biopsy guidance systems market: five major EU markets
3.3.2 Needle-based biopsy products market: five major EU markets
3.3.2.1 Competitors
3.3.3 Other biopsy products market: five major EU markets
3.4 Market forecast: Japan
3.4.1 Biopsy guidance systems market: Japan
3.4.2 Needle-based biopsy products market: Japan
3.4.2.1 Competitors
3.4.3 Other biopsy products market: Japan
3.5 Market forecast: RoW
3.5.1 Biopsy guidance systems market: RoW
3.5.2 Needle-based biopsy products market: RoW
3.5.2.1 Competitors
3.5.3 Other biopsy products market: RoW
3.6 Bibliography

Appendix: Company Listing

List of Exhibits:
Exhibit ES-1: Global biopsy devices market, share by country/region, 2016
Exhibit ES-2: Global biopsy devices market, share by product type, 2016
Exhibit 1-1: Age-standardized cancer incidence and mortality cases (000s), 2012
Exhibit 1-2: Highest age-standardized rates for all cancers, top 10 countries, 2012
Exhibit 1-3: Age-standardized rates of cancer, select countries, 2012
Exhibit 1-4: Estimated incidence of the five most common cancer types worldwide, 2012
Exhibit 1-5: Estimated number of cancer deaths, select countries, 2012
Exhibit 2-1: Select images of core needle biopsy devices
Exhibit 2-2: Select images of fine needle aspiration devices
Exhibit 2-3: Select images of vacuum-assisted biopsy devices
Exhibit 2-4: Select images of bone and bone marrow biopsy devices
Exhibit 2-5: Select images of biopsy forceps
Exhibit 2-6: Select images of biopsy guidance systems
Exhibit 3-1: Biopsy products, global market forecast, 2016-21
Exhibit 3-2: Global biopsy product sales by product segment, combined market forecast ($m), 2016-21
Exhibit 3-3: Average sale price for biopsy products
Exhibit 3-4: Total biopsy product sales by end-user, combined market forecast ($m), 2016-21
Exhibit 3-5: Global biopsy product sales by country/region, combined market forecast ($m), 2016-21
Exhibit 3-6: Global biopsy products market, share by country/region, 2016
Exhibit 3-7: Global biopsy guidance systems market, share by supplier, 2016
Exhibit 3-8: Global needle-based biopsy products market, share by supplier, 2016
Exhibit 3-9: US biopsy products, combined market forecast, 2016-21
Exhibit 3-10: US biopsy guidance systems, market forecast, 2016-21
Exhibit 3-11: US needle-based biopsy products, market forecast, 2016-21
Exhibit 3-12: US needle-based biopsy products market, share by supplier, 2016
Exhibit 3-13: US other biopsy products, market forecast, 2016-2
Exhibit 3-14: Five major EU markets biopsy products, combined market forecast, 2016-21
Exhibit 3-15: Five major EU markets biopsy guidance systems, market forecast, 2016-21
Exhibit 3-16: Five major EU markets needle-based biopsy products, market forecast, 2016-21
Exhibit 3-17: Five major EU markets needle-based biopsy products market, share by supplier, 2016
Exhibit 3-18: Five major EU markets other biopsy products, market forecast, 2016-21
Exhibit 3-19: Japan biopsy products, combined market forecast, 2016-21
Exhibit 3-20: Japan biopsy guidance systems, market forecast, 2016-21
Exhibit 3-21: Japan needle-based biopsy products, market forecast, 2016-21
Exhibit 3-22: Japan needle-based biopsy products market, share by supplier, 2016
Exhibit 3-23: Japan other biopsy products, market forecast, 2016-21
Exhibit 3-24: Rest of the World biopsy products, combined market forecast, 2016-21
Exhibit 3-25: Rest of the World biopsy guidance systems, market forecast, 2016-21
Exhibit 3-26: Rest of the World needle-based biopsy products, market forecast, 2016-21
Exhibit 3-27: Rest of World needle-based biopsy products market, share by supplier, 2016
Exhibit 3-28: Rest of the World other biopsy products, market forecast, 2016-21
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll